Yissum - Research Development Company of the Hebrew University posted this:Vaccinate Against Mycobacteriosis in Fish Using Mycobacterium MarinumMutant Mycobacterium marinum bacteria as a vaccine against Mycobacteriosis in fish Project ID : 24-2018-4681
Yissum - Research Development Company of the Hebrew University posted this:Non-Invasive, Early Pregnancy Test for Dairy Cattle (Through Milk)Cluster11 A METHOD FOR DETERMINE PROGESTERONE LEVELS IN MILK OF A LACTATING COW A non invasive, pragnancy test that can indicate for success insemination and reproductive status in lactating cows on day 17 from insemination Project ID : 8-2014-3070
Yissum - Research Development Company of the Hebrew University posted this:Non-Invasive Method for Identifying Gender and Fertility of Eggs Before HatchingCluster11 A system that can sort avian eggs by detecting pre-incubation fertility and pre-hatching sexing in a non-invasive procedure Project ID : 8-2009-2198
DIT Hothouse posted this:New Farming Technology: The Slurry Solver - A low cost technology to make slurry greener and saferThe Slurry Solver offers a new, low-cost approach for cattle farmers to improve health and safety around tanks, to capture and use renewable energy and to improve the quality and lessen the environmental impact of the slurry their farms produce.
Universidad de Alcalá-OTRI posted this:Salts of pyridazino[2,3-a]pyrrolo[2,1-c]quinoxaline for the treatment of leishmania infections and diseases that involve the protein tyrosine phosphatise 1B (metabolic syndrome, diabetes and obesity)Research groups from the Department of Organic Chemistry and Inorganic Chemistry and the Department of Systems Biology of the University of Alcalá have developed pyridazino[2,3-a]pirrolo[2,1-c]-quinoxalinium salts as therapeutic agents in the treatment of leishmaniasis, metabolic syndrome, diabetes and obesity. The compounds exhibit high activity and selectivity for the Leishmania parasite, and they provide a new therapeutic tool for the treatment of type 2 diabetes. The group seeks pharmaceutical companies to reach licensing agreements or collaboration and commercial agreements with technical assistance.
Centre Technology Transfer CITTRU posted this:Staphylococcus pseudintermedius & bacteriocins – various applicationsThe subject of the present offer is new bacterial strain Staphylococcus pseudintermedius Sp222, isolated from dog pathologic dermal lesions. The offer includes also peptide and protein bacteriocins produced by S. pseudintermedius Sp222. These bacteriocins exhibit a broad spectrum of biological activities: - bacteriocin BacSp222 is able to kill a variety of Gram+ bacteria strains, including the methicillin resistant S. aureus (MRSA) strain. It is also cytotoxic towards selected eukaryotic cells and is resistant to action of proteolytic enzymes (either eukaryotic or prokaryotic) as well as to high temperature. The biological activity of BacSp222 is sustained even after limited fragmentation of its molecule by chemical reagents; - lysostaphin Sp222 has an ability to effectively lyse (and, in consequence, to kill) the cells of Gram+ bacteria.
DIT Hothouse posted this:BovAlert: Priority Animal Health TestingBovAlert is an electrochemical diagnostic device which tests the milk of animal herds for liver fluke, providing quick and easy information regarding disease status. The technology consists of a handheld electronic reader and an assay card for on-site field testing and validation.
Alphanosos posted this:Effiskin(r), a veterinary hygiene product adapted to dogs with pyoderma prone skinsWe are looking for distributors and/or licensees for Effiskin(r). This hygiene product is a lotion formulated around our patent pending alternative to antibiotics and chlorhexidine, a WECMEP (Water Extracts of Complex Mixes of Edible Plants) with a great safety profile. Successful animal model results and user testimony are available. Available as bulk formulation or finished product (spray), also for rebranding.
RAMOT at Tel Aviv University Ltd. posted this:Brain Injury Animal ModelsCognitive and behavioral measurements in mice, suitable for drug evaluation and medical device development in two animal models for brain injury in mice (minimal traumatic brain injury and blast-brain injury). Project ID : 12-2011-200
RAMOT at Tel Aviv University Ltd. posted this:Behavioral Animal ModelsBehavioral test services including pain, cognition, memory and motility in schizophrenia, depression and anxiety, and Carageenan-induced inflammation and pain. Ex vivo brain tissue services include brain tissue dissection and analysis, and protein analysis. Project ID : 12-2011-201
RAMOT at Tel Aviv University Ltd. posted this:Nanomedicine and RNAA multidisciplinary approach to research, including, to name a few, immunology, cell and molecular biology, protein engineering, genetics. Services include PK and bio-distribution of drugs in mice models and in vivo validation of new drug targets using RNA interference. Project ID : 12-2011-207
RAMOT at Tel Aviv University Ltd. posted this:Ophthalmic TestingConsultation and lab services are offered, with a focus on eye-related medical innovations from concept through to clinical trials. Project ID : 12-2011-212
RAMOT at Tel Aviv University Ltd. posted this:Nanoscale electrical characterization of nanostrctures and devicesNanoscale electrical characterization of nanostrctures and devices, Kelvin probe force microscopy (KPFM), Nanowires and nanowire transistors, Solar Cells, Organic semiconductor devices and materials, Biological Field effect Transistors. Project ID : 12-2013-466
RAMOT at Tel Aviv University Ltd. posted this:Cardiovascular and Physiological Assessment in Animal ModelsExperiments in small and large animals including heart function and molecular imaging. Services also include recombinant DNA methods, genetic studies, and a histopathology lab. Project ID : 12-2011-203